Authorization

Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year-End 2021 Results

ALHAMBRA, Calif., Feb. 24, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced its consolidated financial results for the fourth quarter and year ended December 31, 2021.
Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year-End 2021 Results
Financial Highlights for Fourth Quarter 2021:

Earnings per share - diluted ("EPS - diluted") of $0.30 per share, an increase of 11% from $0.27 per share for the prior-year quarter



Total revenue of $195.1 million, an increase of 10% from $176.8 million for the prior-year quarter



Q4 net income attributable to ApolloMed of $13.8 million, an increase of 37% from $10.1 million for the prior-year quarter

Financial Highlights for the Year Ended December 31, 2021:

EPS - diluted of $1.63 per share, an increase of 61% from $1.01 per share for the prior year



Total revenue of $773.9 million, an increase of 13% from $687.2 million for the prior year



Net income attributable to ApolloMed of $73.9 million, an increase of 95% from $37.9 million for the prior year



Adjusted EBITDA of $174.2 million, an increase of 34% from $129.9 million for the prior year(1)



Cash and cash equivalents of $233.1 million at December 31, 2021

(1) See "Reconciliation of Net Income to EBITDA and Adjusted EBITDA" and "Use of Non-GAAP Financial Measures" below for additional information.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Сентябрь 2022    »
ПнВтСрЧтПтСбВс
 1234
567891011
12131415161718
19202122232425
2627282930